Cue Biopharma, Inc. - Common Stock, par value $0.001 per share (CUE)

CUSIP: 22978P106

Q2 2023 13F Holders as of 30 Jun 2023

Holder snapshot 7 signals
Share change
+1,799,013
Put/Call ratio
49%
SEC-reported price per share
$3.65
Indexed holders
77
Value change
+$6,687,288
Number of buys
51
Open additional details 1 more signal available
Number of sells
22
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
7,559,966

Security key

22978P106

Report period

Q2 2023

Indexed institutions

77

Top holders

10

Ownership snapshot

Top reported holders of CUE - Cue Biopharma, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Mark E. Strome
Disclosed value leader
Slate Path Capital LP
Comparable rows
1/15
Latest evidence
31 Mar 2023
13D/G 13F 3/4/5 Lead comparable stake: 5% 14 rows are not safely comparable across share classes. 13D/G row: Mark E. Strome Showing 1-6 of 15 holder rows.

Quick read

Mark E. Strome leads the comparable SEC ownership view at 5%.

1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Mark E. Strome's linked filing trail.
Comparable ownership Top 1
Mark E. Strome 5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Mark E. Strome
13D/G
5%
Reported 13D/G · 14 Nov 2022
$1,862,968
2,166,242 shares
$0 14 Nov 2022
Slate Path Capital LP
13F
Company
13F
—
denominator unverified
$8,576,764
2,402,455 shares
— 31 Mar 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$5,903,338
1,653,596 shares
— 31 Mar 2023
Prosight Management, LP
13F
Company
13F
—
denominator unverified
$4,112,122
1,151,855 shares
— 31 Mar 2023
Bleichroeder LP
13F
Company
13F
—
denominator unverified
$2,695,450
755,028 shares
— 31 Mar 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$2,372,000
664,426 shares
— 31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
77
Shares
13,849,849
Indexed holders
77
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 indexed holders
62
Q2 2023 indexed holders
77
Indexed holder difference
15
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 value Q2 2023 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .